Blue Light Cystoscopy With Cysview® Registry

RecruitingObservational study

Who can join

Ages 18 and older · All sexes

Full eligibility criteria

Inclusion Criteria:

* Adult \>18 years old
* Suspected or known non-muscle invasive bladder cancer on the basis of a prior cystoscopy

Exclusion Criteria:

* Porphyria
* Gross hematuria
* Known hypersensitivity to hexaminolevulinate or aminolevulinate derivatives

About the study

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.

What is being tested

Hexaminolevulinate hydrochloride (HCL) (drug)
Karl Storz D-Light C Photodynamic Diagnostic (PDD) system (device)

Sponsor: Photocure · Participants: 4,400 · Started: 2014-04

Contact the study team

Chad McKee, PhD · Phone: (919) 780-0417

Official record on ClinicalTrials.gov — NCT02660645

Locations in the U.S.

Alabama	The University of Alabama at Birmingham, Birmingham
Arizona	Mayo Clinic, Phoenix
California	USC/Norris Comprehensive Cancer Center, Los Angeles University of California Los Angeles, Los Angeles VA Palo Alto Health Care System, Palo Alto University of California, San Francisco, San Francisco
District of Columbia	Sibley Memorial Hospital, Washington D.C.
Georgia	Emory University School of Medicine, Atlanta
Illinois	Northwestern University, Chicago Northshore University Health System, Evanston
Indiana	Indiana University School of Medicine, Indianapolis
Kansas	University of Kansas Medical Center, Kansas City
Maryland	Johns Hopkins Medicine, Baltimore
Minnesota	University of Minnesota, Minneapolis
New York	NYU Langone's Perlmutter Cancer Center, New York
Ohio	Ohio State University, Columbus Ohio State University Wexner Medical Center, Columbus
South Carolina	Lexington Medical Center, West Columbia
Texas	UT Southwestern, Dallas Michael E. DeBakey VA Medical Center, Houston
Washington	University of Washington Medicine, Seattle

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.